Experts discuss treatment sequencing after progression in multiple myeloma

In a recent video segment, Dr. Ajay K. Nooka, Dr. Noopur S. Raje and Dr. Surbhi Sidana lead a discussion on how to approach treatment sequencing for patients whose multiple myeloma has progressed.

The panel examines options for relapsed and refractory disease, weighing factors such as prior therapy exposure, disease biology and patient fitness to guide the next line of treatment.

The conversation is part of a broader educational series that covers many aspects of relapsed and refractory multiple myeloma, including emerging data, cellular therapy candidates and access barriers.